RBI
AXSM icon

Raiffeisen Bank International’s Axsome Therapeutics AXSM Stock Holding History

Raiffeisen Bank International’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$67.6K – 822
2025
Q2 		$62.6K Hold
600
– – ﹤0.01% 489
2025
Q1 		$70K Hold
600
– – ﹤0.01% 504
2024
Q4 		$51.4K Buy
+600
New +$55.2K ﹤0.01% 519

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raiffeisen Bank International's AXSM Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 600 shares — an estimated $67.6K sold.

Raiffeisen Bank International first reported a position in AXSM in Q4 2024 and held it in 3 quarters. The position peaked at $70K in Q1 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 600 Axsome Therapeutics shares in Q3 2025, an estimated $67.6K.
  • Raiffeisen Bank International first reported a position in Axsome Therapeutics in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Axsome Therapeutics position peaked at $70K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.